Get the Stockscreener App
8.63
1.26%
-0.11
After Hours:
8.63
Teladoc Health Inc stock is traded at $8.63, with a volume of 9.59M.
It is down -1.26% in the last 24 hours and up +11.64% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$8.74
Open:
$8.74
24h Volume:
9.59M
Relative Volume:
1.32
Market Cap:
$1.52B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-7.2521
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
-8.77%
1M Performance:
+11.64%
6M Performance:
+20.03%
1Y Performance:
-4.11%
1-Day Range:
$8.46
$9.15
1-Week Range:
$7.96
$9.77
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.63 | 1.55B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Evercore ISI Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Q3 2025 Earnings Call Transcript - Insider Monkey
How to build a custom watchlist for Teladoc Health Inc.Quarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com
Why Teladoc Health Inc. stock could be next big winnerMarket Growth Summary & Precise Swing Trade Alerts - newser.com
How Teladoc Health Inc. stock valuations compare to rivalsMarket Rally & Smart Investment Allocation Tips - newser.com
Will Teladoc Health Inc. (4LL) stock outperform small cap peers2025 Performance Recap & Real-Time Volume Analysis - newser.com
How Teladoc Health Inc. stock performs after earningsWeekly Trade Analysis & Risk Controlled Swing Alerts - newser.com
Can trapped investors hope for a rebound in Teladoc Health Inc.2025 Price Targets & Risk Controlled Daily Plans - newser.com
Can Teladoc Health Inc. (4LL) stock sustain revenue momentumJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
How Teladoc Health Inc. (4LL) stock behaves under inflation pressureJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com
Will a bounce in Teladoc Health Inc. offer an exit2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Will Teladoc Health Inc. (4LL) stock enhance shareholder valueMarket Weekly Review & Safe Capital Growth Tips - newser.com
Multi asset correlation models including Teladoc Health Inc.Dividend Hike & Verified Trade Idea Suggestions - newser.com
How to recover losses in Teladoc Health Inc. stockWeekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
What downside risks could hit Teladoc Health Inc. (4LL) stockPortfolio Return Summary & Verified Momentum Stock Watchlist - newser.com
Is Teladoc Health Inc. stock a contrarian opportunity2025 Key Lessons & Technical Pattern Based Signals - newser.com
Is Teladoc Health Inc. stock a safe buy before earnings2025 Stock Rankings & Smart Money Movement Tracker - newser.com
Is Teladoc Health Inc. stock a buy before earnings resultsJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Will Teladoc Health Inc. stock boost dividends furtherJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Order flow analysis tools used on Teladoc Health Inc.Quarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Will Teladoc Health Inc. stock return to pre crash levelsEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Teladoc Health (NYSE:TDOC) Issues Q4 2025 Earnings Guidance - MarketBeat
Teladoc Health’s Earnings Call: Resilience Amid Challenges - TipRanks
Teladoc Finds Its Groove With Strong Q3, AI Push - TradingView
Teladoc Health (NYSE:TDOC) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus - Investing.com Canada
Teladoc Health (TDOC): Evercore ISI Group Adjusts Price Target | TDOC Stock News - GuruFocus
Teladoc Health Inc (TDOC) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - Yahoo Finance
Teladoc expands insurance coverage at mental health unit BetterHelp - Healthcare Dive
Why Teladoc (TDOC) Stock Is Trading Up Today - MSN
Teladoc Health, Inc. SEC 10-Q Report - TradingView
When will things look better for Teladoc? - statnews.com
TDOC Q3 CY2025 Deep Dive: Insurance Pivot, International Growth, and Margin Pressures - TradingView
How to integrate Teladoc Health Inc. into portfolio analysis tools2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Trend analysis for Teladoc Health Inc. this week2025 Technical Overview & Technical Pattern Alert System - newser.com
Should you wait for a breakout in Teladoc Health Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
58,450 Shares in Teladoc Health, Inc. $TDOC Bought by Wealth Management Associates Inc. - MarketBeat
Digital Therapeutics and Virtual Care Suite Market Future - openPR.com
How Teladoc Health Inc. (4LL) stock compares with top peersPortfolio Value Summary & Intraday High Probability Setup Alerts - newser.com
Teladoc Health Reports Q3 2025 Financial Results - TipRanks
Teladoc Health (TDOC) Reports Strong Q3 Performance and Strategi - GuruFocus
Teladoc Inc earnings missed by $0.02, revenue topped estimates - Investing.com
Teladoc (TDOC) Q3 2025 Earnings Call Transcript - The Globe and Mail
Teladoc’s Revenue Tops Forecasts Even As Losses Deepen - Finimize
Teladoc (TDOC) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo! Finance Canada
Teladoc Health Reports Third Quarter 2025 Results - MarketScreener
Teladoc Health (TDOC) Faces Challenges Despite Revenue Consisten - GuruFocus
Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Teladoc (TDOC) Reports Q3 Revenue Slightly Below Expectations - GuruFocus
Teladoc (TDOC) Announces Projected Q4 Revenue, Expects Strong Pe - GuruFocus
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.38%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):